Skip to content

Non-disabling Ischemic Cerebrovascular Event With Apathy

Non-disabling Ischemic Cerebrovascular Event With Apathy: A Prospective Registry Trail

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04917237
Enrollment
200
Registered
2021-06-08
Start date
2021-07-10
Completion date
2024-06-10
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apathy, Minor Stroke, Stroke, Transient Ischemic Attack

Keywords

Apathy, minor stroke, Transient Ischemic Attack, Stroke

Brief summary

The burden of non-disabling ischemic cerebrovascular events (NICE) is significantly increased. However, few previous studies have focused on affective impairment after transient ischemic attack (TIA) and minor stroke. Stroke survivors are often described as apathetic. Even though post-stroke apathy (PSA) affects one in three stroke patients,it has not hitherto received much attention. NICE-A is a prospective study aimed to explore the association between baseline apathy and probable incident stroke in a population-based sample of TIA and minor stroke adults.

Detailed description

Transient ischemic attack (TIA) and acute minor ischemic stroke, are common and may leave impermanent or mild neurological deficit, they are termed as non-disabling ischemic cerebrovascular disease (NICE). TIA and minor stroke exhibit the common substantial risk factors for early stroke recurrence and epidemiological characteristic, with approximately 10 to 20% of patients having a stroke within 3 months after the index event. Previous studies has shown that post-stroke apathy (PSA) affects one in three stroke patients, which is consistently associated with a worse level of functional recovery, poorer overall health and poorer quality of life. However, still little is known about the development of TIA and minor stroke patients with apathy. Thus, it is imperative to find the relationships between baseline PSA and probable incident stroke in these patients. NICE is an attractive researching area globally. According to the large quantities of NICE patients in China and the low standardized therapeutic rate, the awareness of TIA and minor stroke is largely insufficient. The purpose of the present NICE-A study is to establish the prevalence, predictors and evolution of symptoms of PSA in TIA and minor stroke patients during the first post-stroke year.

Interventions

None listed

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

≥18 years old Onset of a minor stroke (National Institute of Health stroke scale, NIHSS≤3) and TIA elapsed time from last episode to registry \<1 month

Exclusion criteria

patients who refused to participate in the research, and patients who failed to complete the follow-up protocol. patients with malignant tumors, or patients with severe liver or kidney disease, whose life expectancy is less than 1 year. patients who received endovascular or thrombolytic therapy.

Design outcomes

Primary

MeasureTime frameDescription
Death1 monthDeath from any cause
Stroke recurrence1 monthIschemic stroke

Secondary

MeasureTime frameDescription
Hemorrhagic stroke1 monthCerebral hemorrhage and subaraclmoid hemorrhage
Functional outcome1 monthModified Rankin Scale ≥3

Countries

China

Contacts

Primary ContactXiaoying Bi, MD, PhD
bixiaoying2013@163.com86-13795274796
Backup ContactBingying Du, MD, PhD
15800614142@163.com86-15800614142

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026